The Benefits of Exporting: Engineered Extracellular Vesicles as Promising Vaccine Candidates against Enteric Fever
- PMID: 33468582
- PMCID: PMC8090954
- DOI: 10.1128/IAI.00001-21
The Benefits of Exporting: Engineered Extracellular Vesicles as Promising Vaccine Candidates against Enteric Fever
Abstract
The immunological potential of extracellular vesicles produced by Gram-negative bacteria, the so-called outer-membrane vesicles (OMVs), can be improved by genetic engineering, resulting in vesicles containing multiple immunogens. The potential of this approach for the development of a vaccine candidate for enteric fever was recently demonstrated by G. Gasperini, R. Alfini, V. Arato, F. Mancini, et al. (Infect Immun 89:e00699-20, 2021, https://doi.org/10.1128/IAI.00699-20). This commentary will discuss the use of OMVs to generate vaccines for enteric fever and the promise of this approach for prevention of other infectious diseases.
Keywords: enteric fever; extracellular vesicles; outer membrane vesicles; vaccines.
Copyright © 2021 American Society for Microbiology.
Comment on
-
Salmonella Paratyphi A Outer Membrane Vesicles Displaying Vi Polysaccharide as a Multivalent Vaccine against Enteric Fever.Infect Immun. 2021 Mar 17;89(4):e00699-20. doi: 10.1128/IAI.00699-20. Print 2021 Mar 17. Infect Immun. 2021. PMID: 33318138 Free PMC article.
References
-
- Appiah GD, Hughes MJ, Chatam-Stephens K. 2020. Typhoid & paratyphoid fever. Centers for Disease Control and Prevention, Atlanta, GA.
-
- CDC. 2019. Typhoid vaccine: what you need to know. Centers for Disease Control and Prevention, Atlanta, GA.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
